ImpediMed Ltd (ImpediMed) is a manufacturer of bioimpedance devices with a focus on medical applications in the fluid status domain. The company also designs, manufactures, and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition. It harnesses BIS technologies in the non-invasive clinical assessment and monitoring of fluid status. Its major products include SOZO, SFB7, L-Dex U400, ImpediVET, and DF50. Its products are based on BIS and bioimpedance analysis platform technologies and they obtain readings from a wide frequency range to improve the accuracy of bioimpedance analysis. The company sells its products through distributors in Australia, Europe, and the US. ImpediMed is headquartered in Brisbane, Queensland, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ImpediMed Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ImpediMed Ltd Company Overview
- ImpediMed Ltd Company Snapshot
- ImpediMed Ltd Pipeline Products and Ongoing Clinical Trials Overview
- ImpediMed Ltd - Pipeline Analysis Overview
- Business Description
- ImpediMed Ltd - Key Facts
- ImpediMed Ltd - Major Products and Services
- ImpediMed Ltd Pipeline Products by Development Stage
- ImpediMed Ltd Ongoing Clinical Trials by Trial Status
- ImpediMed Ltd Pipeline Products Overview
- SFB 9
- SFB 9 Product Overview
- SOZO - Renal Failure
- SOZO - Renal Failure Product Overview
- SOZO - Renal Failure Clinical Trial
- SOZO Pro - Lymphedema Analysis
- SOZO Pro - Lymphedema Analysis Product Overview
- SOZO Pro - Protein Calorie Malnutrition Analysis
- SOZO Pro - Protein Calorie Malnutrition Analysis Product Overview
- ImpediMed Ltd - Key Competitors
- ImpediMed Ltd - Key Employees
- ImpediMed Ltd - Key Employee Biographies
- ImpediMed Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ImpediMed Ltd, Recent Developments
- Nov 02, 2023: ImpediMed Receives Additional 510(k) Clearance for SOZO Pro
- Jul 31, 2023: Five Additional Positive Medical Policies Achieved
- Jul 19, 2023: First Top 5 National Payor Covering SOZO Testing for Cancer Patients at Risk for Lymphoedema
- Jun 29, 2023: Impedimed Achieves Critical Mass (80% Covered Lives) For Sozo Reimbursement Coverage in First Key Target State
- Jun 20, 2023: Impedimed Announces Third Medical Policy Covering Sozo Testing for Cancer Patients at Risk for Lymphoedema
- Jun 05, 2023: Impedimed Announces First Published Medical Policy From a Blue Cross Blue Shield Health Plan Covering L-DEX
- May 25, 2023: Impedimed announces first published medical policy covering bioimpedance spectroscopy testing for breast cancer patients
- May 05, 2023: SOZO Pro achieves clearance by U.S. FDA
- Mar 27, 2023: NCCN guidelines updated to recommend regular screening for lymphoedema including with bioimpedance spectroscopy
- Dec 23, 2022: ImpediMed : Update to expected release of NCCN Guidelines
- Appendix
- Methodology
- About the Publisher
- Contact Us
- Disclaimer
- ImpediMed Ltd Pipeline Products and Ongoing Clinical Trials Overview
- ImpediMed Ltd Pipeline Products by Equipment Type
- ImpediMed Ltd Pipeline Products by Indication
- ImpediMed Ltd Ongoing Clinical Trials by Trial Status
- ImpediMed Ltd, Key Facts
- ImpediMed Ltd, Major Products and Services
- ImpediMed Ltd Number of Pipeline Products by Development Stage
- ImpediMed Ltd Pipeline Products Summary by Development Stage
- ImpediMed Ltd Ongoing Clinical Trials by Trial Status
- ImpediMed Ltd Ongoing Clinical Trials Summary
- SFB 9 - Product Status
- SFB 9 - Product Description
- SOZO - Renal Failure - Product Status
- SOZO - Renal Failure - Product Description
- SOZO - Renal Failure - Observational Study of Bioimpedance Spectroscopy (BIS) for Use in a Renal Population
- SOZO Pro - Lymphedema Analysis - Product Status
- SOZO Pro - Lymphedema Analysis - Product Description
- SOZO Pro - Protein Calorie Malnutrition Analysis - Product Status
- SOZO Pro - Protein Calorie Malnutrition Analysis - Product Description
- ImpediMed Ltd, Key Employees
- ImpediMed Ltd, Key Employee Biographies
- ImpediMed Ltd, Other Locations
- ImpediMed Ltd, Subsidiaries
- Glossary
- ImpediMed Ltd Pipeline Products by Equipment Type
- ImpediMed Ltd Pipeline Products by Development Stage
- ImpediMed Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- seca
- Fresenius Medical Care Australia Pty Ltd
- Tanita (Shanghai) Trading Co Ltd
- SELVAS Healthcare Inc
- OMRON Healthcare Singapore Pte Ltd
- Cosmed Srl
